Trial intelligence / Profile preview

Prostaglandin E1 plus heparin vs placebo plus heparin during continuous venovenous hemofiltration

2005-003211-69Phase 3Completed

Sponsor
Medical University of Vienna
Start
Aug 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in acute kidney failure (AKF) comparing Prostaglandin E1 + heparin with Placebo + heparin (2 arms). Primary endpoint: Hemofilter lifespan until first change. Started Aug 2005; status: completed.

02

Drugs

Vasostenoon
03

Conditions

acute kidney failure (AKF)

Beyond the preview

Go deeper on 2005-003211-69.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-003211-69.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call